Title

A Physiologic-Based Approach to the Treatment of a Patient With Hypokalemia

Authors

Authors

A. Asmar; R. Mohandas;C. S. Wingo

Comments

Authors: contact us about adding a copy of your work at STARS@ucf.edu

Abbreviated Journal Title

Am. J. Kidney Dis.

Keywords

Hypokalemia; treatment; replacement; potassium; Liddle syndrome; POTASSIUM HOMEOSTASIS; ALDOSTERONE; NEPHROPATHY; Urology & Nephrology

Abstract

Hypokalemia is common and can be associated with serious adverse consequences, including paralysis, ileus, cardiac arrhythmias, and death. As a result, the body maintains serum potassium concentration within very narrow limits by tightly regulated feedback and feed-forward systems. Whereas the consequences of symptomatic hypokalemia and severe potassium depletion are well appreciated, chronic mild hypokalemia can accelerate the progression of chronic kidney disease, exacerbate systemic hypertension, and increase mortality. Persistent hypokalemia may reflect total-body potassium depletion or increased renal potassium clearance. In a patient with simple potassium depletion, potassium replacement therapy should correct serum potassium concentration, but may have little effect when renal potassium clearance is abnormally increased from potassium wasting. In such cases, the addition of potassium-sparing diuretics might be helpful. Serum potassium concentration is an inaccurate marker of total-body potassium deficit. Mild hypokalemia may be associated with significant total-body potassium deficits and conversely, total-body potassium stores can be normal in patients with hypokalemia due to redistribution. The speed and extent of potassium replacement should be dictated by the clinical picture and guided by frequent reassessment of serum potassium concentration. The goals of therapy should be to correct a potassium deficit, if present, without provoking hyperkalemia. Oral replacement is preferred except when there is no functioning bowel or in the setting of electrocardiogram changes, neurologic symptoms, cardiac ischemia, or digitalis therapy. Am J Kidney Dis. 60(3): 492-497. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.

Journal Title

American Journal of Kidney Diseases

Volume

60

Issue/Number

3

Publication Date

1-1-2012

Document Type

Article

Language

English

First Page

492

Last Page

497

WOS Identifier

WOS:000307941200024

ISSN

0272-6386

Share

COinS